tm logo
LYELL
ADVERTISED

on 09 Oct 2024

Last Applicant/ Owned by

LYELL IMMUNOPHARMA INC.

201 Haskins WaySouth San Francisco, CA 94080

US

Serial Number

1969518 filed on 12th Jun 2019

Correspondent Address

SUITE 2600, 160 ELGIN STREETOTTAWA

ONTARIO

CA

K1P1C3

LYELL

Trademark usage description

pharmaceutical preparations and drugs for the treatment of cancer, auto-immune diseases, and infectious diseases, namely, sexually transmitted disease Read More

Classification Information


Class [005]
Pharmaceutical preparations and drugs for the treatment of cancer, auto-immune diseases, and infectious diseases, namely, sexually transmitted diseases, respiratory infections, eye infections, bacterial skin infections, fungal skin infections, viral skin infections, parasitic skin infections, psoriasis, and eczema; cells for medical or clinical purposes, namely, genetically modified human immune cells for cell therapy, epigenetically modified human immune cells for cell therapy, rejuvenated and partially reprogrammed human cells for cell therapy, biological preparations made from human immune cells, rejuvenated somatic cells, and rejuvenated and partially reprogrammed human cells for the treatment of cancer; pharmaceutical preparations for cell therapy for medical or clinical purposes; pharmaceutical preparations for gene therapy for medical or clinical purposes; kits comprised of genetically modified human immune cells for cell therapy, epigenetically modified human immune cells for cell therapy, rejuvenated and partially reprogrammed human cells for cell therapy, biological preparations made from human immune cells, rejuvenated somatic cells, and rejuvenated and partially reprogrammed human cells for the treatment of cancer cells for medical purposes and pharmaceutical preparations for the treatment of sexually transmitted diseases, cancer, auto immune diseases, and infectious diseases, namely, sexually transmitted diseases, respiratory infections, eye infections, bacterial skin infections, fungal skin infections, viral skin infections, parasitic skin infections, psoriasis, and eczema


Classification kind code

11

Class [042]
Pharmaceutical research and development; development of pharmaceutical preparations and drugs; development of pharmaceutical preparations and drugs for the treatment of cancer, auto-immune diseases, and infectious diseases; development of pharmaceutical preparations and drugs in the field of immunotherapy; development of pharmaceutical preparations and drugs in the field of cell therapy; scientific research and development in the field of pharmaceuticals and biopharmaceuticals; medical research laboratory services; medical and scientific research in the field of pharmaceuticals and biopharmaceuticals; conducting clinical trial regarding pharmaceutical preparations and drugs for the treatment of cancer, auto immune diseases, and infectious diseases; conducting clinical trial regarding pharmaceutical preparations and drugs in the field of immunotherapy; conducting clinical trial regarding pharmaceutical preparations and drugs in the field cell therapy


Classification kind code

11

Class [044]
Medical services in the nature of information, advisory and consultancy services in the field of medical testing services


Classification kind code

11

Mark Details


Serial Number

1969518

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 42
on 09th Oct 2024
Advertised
Submitted for opposition 26
on 16th Sep 2024
Approved
Submitted for opposition 27
on 16th Sep 2024
Approval Notice Sent
Submitted for opposition 22
on 22nd Feb 2024
Search Recorded
Submitted for opposition 20
on 22nd Feb 2024
Examiner's First Report
Submitted for opposition 287
on 31st May 2022
Pre-Assessment Letter Sent
Submitted for opposition 135
on 02th May 2022
Amendment to Application
Submitted for opposition 31
on 18th Jun 2019
Formalized
Submitted for opposition 30
on 12th Jun 2019
Filed
Submitted for opposition 1
on 12th Jun 2019
Created